Locations
South San Francisco, CA, USA · Berkeley, CA, USA
industry
Biotechnology · DeepTech · Health
Size
11-50 employees
Stage
Series A
founded in
2016
Gen Edit is a rapidly growing, early-stage company focused on revolutionizing genetic medicine through its innovative Nano Galaxy® delivery platform. This proprietary technology addresses historical delivery challenges in genetic therapies, enabling effective treatment for a wide range of diseases. With a strong interdisciplinary team and a commitment to impactful data and creative solutions, Gen Edit is positioned to transform the landscape of gene therapies and improve patient outcomes. The company is actively advancing its pipeline of therapeutic candidates and fostering collaborations to expand its reach in the genetic medicine market.
Something looks off?On-site & Remote